Clinical Profile of Eprosartan: A Different Angiotensin II Receptor Blocker

por Blankestijn, P. J, Rupp, H
Publicado 2008

Percutaneous renal denervation for the treatment of resistant essential hypertension; the first Dutch experience

por Voskuil, M., Verloop, W. L., Blankestijn, P. J., Agostoni, P., Stella, P. R., Doevendans, P. A.
Publicado 2011

High-Target Hemodiafiltration Convective Dose Achieved in Most Patients in a 6-Month Intermediary Analysis of the CONVINCE Randomized Controlled Trial

por Vernooij, Robin W.M., Hockham, C., Barth, C., Canaud, B., Cromm, K., Davenport, A., Hegbrant, J., Rose, M., Strippoli, G.F.M., Török, M., Woodward, M., Bots, M.L., Blankestijn, P.J.
Publicado 2023

Quality of life as indicator of poor outcome in hemodialysis: relation with mortality in different age groups

por van Loon, I. N., Bots, M. L., Boereboom, F. T. J., Grooteman, M. P. C., Blankestijn, P. J., van den Dorpel, M. A., Nubé, M. J., Ter Wee, P. M., Verhaar, M. C., Hamaker, M. E.
Publicado 2017

The position of renal denervation in treatment of hypertension: an expert consensus statement

por Zeijen, V. J. M., Kroon, A. A., van den Born, B. H., Blankestijn, P. J., Meijvis, S. C. A., Nap, A., Lipsic, E., Elvan, A., Versmissen, J., van Geuns, R. J., Voskuil, M., Tonino, P. A. L., Spiering, W., Deinum, J., Daemen, J.
Publicado 2022